Cargando…
Potent inhibition of miR-27a by neomycin–bisbenzimidazole conjugates
miRNAs are important components of regulatory networks that control gene expression and have implications in various diseases including cancer. Targeting oncogenic miRNAs with small molecules is currently being explored to develop cancer therapeutics. Here, we report the development of dual binding...
Autores principales: | Nahar, Smita, Ranjan, Nihar, Ray, Arjun, Arya, Dev P., Maiti, Souvik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947510/ https://www.ncbi.nlm.nih.gov/pubmed/29861909 http://dx.doi.org/10.1039/c5sc01969a |
Ejemplares similares
-
Fine-tuning miR-21 expression and inhibition of EMT in breast cancer cells using aromatic-neomycin derivatives
por: Ghosh, Arpita, et al.
Publicado: (2021) -
Gram-negative synergy and mechanism of action of alkynyl bisbenzimidazoles
por: Chamberlin, Jordan, et al.
Publicado: (2019) -
Targeting C-myc G-Quadruplex: Dual Recognition by Aminosugar-Bisbenzimidazoles with Varying Linker Lengths
por: Ranjan, Nihar, et al.
Publicado: (2013) -
Parallel G-quadruplex recognition by neomycin
por: Ranjan, Nihar, et al.
Publicado: (2023) -
Surface Dependent Dual Recognition of a G-quadruplex DNA With Neomycin-Intercalator Conjugates
por: Ranjan, Nihar, et al.
Publicado: (2020)